Close Menu

NEW YORK(GenomeWeb) – Where mass spec-based microbiology is concerned, MALDI has largely led the way, with commercial platforms from Bruker and BioMérieux in recent years receiving regulatory approvals and winning clinical customers around the world.

If the Mass Spectrometry Applications to the Clinical Laboratory annual meeting held last month inSan Diegois any indication, though, the clinical microbiology field is looking beyond MALDI for the next generation of mass spec-based tools.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.